Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marta Gomez-Nunez"'
Autor:
Tatyana Korontsvit, Victoriya Zakhaleva, Rena J. May, Tao Dao, Marta Gomez-Nunez, Javier Pinilla-Ibarz, David A. Scheinberg
Publikováno v:
Blood. 106:4483-4483
Major Histocompatibility Complex class I (MHC-I) molecules present antigenic peptides to T cells on the cell surface as a prerequisite for stimulating cytotoxic T cell response. Thus, the ability to reliably identify the peptides that can bind to MHC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44c5851e39b3e048ad228365ce41625e
https://doi.org/10.1182/blood.v106.11.4483.4483
https://doi.org/10.1182/blood.v106.11.4483.4483
Autor:
Marta Gomez-Nunez, Javier Pinilla-Ibarz, Tao Dao, Rena J. May, David A. Scheinberg, Tatyana Korontsvit, Victoriya Zakhaleva
Publikováno v:
Blood. 106:2868-2868
Intracellular processing of the breakpoint products of the bcr-abl fusion gene may generate novel peptides that, if capable of binding to HLA class I molecules, would be potential targets for a cytotoxic T lymphocyte (CTL) response. In humans, peptid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3555fb665bd6ca33f5bebc841fc6acf1
https://doi.org/10.1182/blood.v106.11.2868.2868
https://doi.org/10.1182/blood.v106.11.2868.2868
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100712- (2020)
Summary: This case report describes a 65-year-old man with a Rendu-Osler-Weber syndrome with secondary chronic anaemia, who received multiple intravenous (IV) iron infusions and sustained diffuse bone pain secondary to multiple insufficiency fracture
Externí odkaz:
https://doaj.org/article/3eef78824c8248289c162f9a2ea0837a
Autor:
Marta Gómez-Nuñez, Kurtis J Haro, Tao Dao, Deming Chau, Annie Won, Sindy Escobar-Alvarez, Victoriya Zakhaleva, Tatyana Korontsvit, David Y Gin, David A Scheinberg
Publikováno v:
PLoS ONE, Vol 3, Iss 12, p e3938 (2008)
Wilms tumor protein (WT1) is a transcription factor selectively overexpressed in leukemias and cancers; clinical trials are underway that use altered WT1 peptide sequences as vaccines. Here we report a strategy to study peptide-MHC interactions by in
Externí odkaz:
https://doaj.org/article/30d4d05cd0184de5a54cb2a7878f3a05